
Zydus Lifesciences Limited has informed the Exchange regarding a press release dated April 16, 2025, titled "Zynext Ventures Invests in Feldan Therapeutics to Drive Innovation in Intracellular Drug Delivery".
Filed with NSE ·

Zydus Lifesciences Limited has informed the Exchange regarding a press release dated April 16, 2025, titled "Zynext Ventures Invests in Feldan Therapeutics to Drive Innovation in Intracellular Drug Delivery".
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences